John DeNuzzio is the Owner and Principal of Birch Hollow Technologies LLC, a medtech consulting firm focused on advancing medical innovations from concept through commercialization. He partners with companies across the healthcare spectrum to translate strategy into execution, aligning clinical need, technical feasibility, and commercial opportunity.
With more than 30 years of experience spanning pharmaceuticals and medical devices, John has brought complex products to market in drug delivery platforms, wearable systems, in vitro diagnostics, and genomic automation technologies.
At Becton, Dickinson and Company (BD), John held senior leadership roles across diabetes care, infectious disease diagnostics, genomics, and infusion systems. He directed global R&D organizations, led end-to-end product development programs, and partnered with third-party developers and manufacturers worldwide to deliver best-in-class systems.
Birch Hollow Technologies partners with emerging and established medtech companies to advance products from early concept through development, regulatory submission, and commercial launch. We focus on solving critical technical challenges, crafting winning technical and business strategies, and aligning internal teams with external experts to deliver breakthrough innovations.
John received BSE and Ph.D. degrees from the University of Pennsylvania in Bioengineering and Materials Science.
